Drawing for MEDALLION EQUINE

USPTO serial 88582030

MEDALLION EQUINE

Reviewed by CopyMark Law Group

Reg. 6732197Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
WATSON, BRIDGET ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MEDALLION EQUINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Noel C. Gillespie

Noel C. Gillespie PROCOPIO, CORY, HARGREAVES & SAVITCH LLP525 B STREET, SUITE 2200SAN DIEGO, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements for animals; nutritional supplements for foodstuffs for animalsACTIVEFeb 7, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 9, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 8, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 19, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 18, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 18, 2022EX4GSOU EXTENSION 4 GRANTED—
Mar 14, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 3, 2022IUAFUSE AMENDMENT FILED—
Mar 3, 2022EXT4SOU EXTENSION 4 FILED—
Mar 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 11, 2021EX3GSOU EXTENSION 3 GRANTED—
Aug 11, 2021EXT3SOU EXTENSION 3 FILED—
Aug 11, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2021EX2GSOU EXTENSION 2 GRANTED—
Feb 17, 2021EXT2SOU EXTENSION 2 FILED—
Feb 17, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 3, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 3, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 22, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 20, 2020EX1GSOU EXTENSION 1 GRANTED—
Aug 20, 2020EXT1SOU EXTENSION 1 FILED—
Aug 20, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 7, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 7, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 2, 2019ALIEASSIGNED TO LIE—
Nov 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Nov 19, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 19, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 19, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 16, 2019DOCKASSIGNED TO EXAMINER—
Sep 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance